CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target lowered by Bank of America from $98.00 to $85.00 in ...

Research from an Arizona State finance professor finds that most stocks over the long run don’t perform, but that a few ...

VV seeks to match the performance of the CRSP US Large Cap Index before fees and expenses. The CRSP US Large Cap Index includes U.S. companies that comprise the top 85% of investable market ...

Nature's Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the full commercial availability of NTxscribe®, a benchtop, ...

BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, today announced its selection by MarginEdge, a provider of restaurant management solutions, as its North American ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The animal spirits driving 2024’s market performance reawakened in Q4, fueled by speculative momentum and low volatility, ...

Mid-cap stocks represent companies valued at between $2 billion and $10 billion. If they give investors a reason to be ...

Legacy Private Trust Co. lowered its stake in iShares S&P Mid-Cap 400 Growth ETF (NYSEARCA:IJK – Free Report) by 2.1% during ...

NASCAR asks federal judge to dismiss teams' antitrust lawsuit (January 8, 2025, 6:31 PM ET) Helio Castroneves to attempt to qualify for Daytona 500 (January 6, 2025, 5:49 PM ET) ...

“With CRSP as the leading equities pricing data used by academic researchers, and OptionMetrics considered by many to be the ...